1369482-18-7 Usage
Uses
Used in Medicinal Chemistry Research:
3-Allyl-4-(benzyloxy)quinolin-2(1H)-one is used as a research compound for exploring its potential biological activities and medicinal properties. Its unique structure and potential pharmacological effects make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Drug Development:
In the pharmaceutical industry, 3-allyl-4-(benzyloxy)quinolin-2(1H)-one is used as a lead compound in the development of new drugs. Its potential biological activities and medicinal properties are being investigated to identify possible applications in treating various diseases and conditions.
Used in Chemical Synthesis:
3-Allyl-4-(benzyloxy)quinolin-2(1H)-one can also be used as a starting material or intermediate in the synthesis of other related compounds with potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science. Its unique structural features make it a versatile building block for the creation of novel molecules with desired properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1369482-18-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,9,4,8 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1369482-18:
(9*1)+(8*3)+(7*6)+(6*9)+(5*4)+(4*8)+(3*2)+(2*1)+(1*8)=197
197 % 10 = 7
So 1369482-18-7 is a valid CAS Registry Number.
1369482-18-7Relevant academic research and scientific papers
HCV NS3 protease inhibitors
-
Page/Page column 83, (2016/06/01)
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 63, (2013/06/05)
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
HCV NS3 PROTEASE INHIBITORS
-
Page/Page column 56-57, (2012/04/10)
The present invention relates to macro-cyclic compounds of formula I that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections
